BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 34103329)

  • 1. Enhancer Hijacking Drives Oncogenic
    Montefiori LE; Bendig S; Gu Z; Chen X; Pölönen P; Ma X; Murison A; Zeng A; Garcia-Prat L; Dickerson K; Iacobucci I; Abdelhamed S; Hiltenbrand R; Mead PE; Mehr CM; Xu B; Cheng Z; Chang TC; Westover T; Ma J; Stengel A; Kimura S; Qu C; Valentine MB; Rashkovan M; Luger S; Litzow MR; Rowe JM; den Boer ML; Wang V; Yin J; Kornblau SM; Hunger SP; Loh ML; Pui CH; Yang W; Crews KR; Roberts KG; Yang JJ; Relling MV; Evans WE; Stock W; Paietta EM; Ferrando AA; Zhang J; Kern W; Haferlach T; Wu G; Dick JE; Klco JM; Haferlach C; Mullighan CG
    Cancer Discov; 2021 Nov; 11(11):2846-2867. PubMed ID: 34103329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 14q32 rearrangements deregulating BCL11B mark a distinct subgroup of T-lymphoid and myeloid immature acute leukemia.
    Di Giacomo D; La Starza R; Gorello P; Pellanera F; Kalender Atak Z; De Keersmaecker K; Pierini V; Harrison CJ; Arniani S; Moretti M; Testoni N; De Santis G; Roti G; Matteucci C; Bassan R; Vandenberghe P; Aerts S; Cools J; Bornhauser B; Bourquin JP; Piazza R; Mecucci C
    Blood; 2021 Sep; 138(9):773-784. PubMed ID: 33876209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
    Montefiori LE; Mullighan CG
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A far downstream enhancer for murine Bcl11b controls its T-cell specific expression.
    Li L; Zhang JA; Dose M; Kueh HY; Mosadeghi R; Gounari F; Rothenberg EV
    Blood; 2013 Aug; 122(6):902-11. PubMed ID: 23741008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrated genome-wide genotyping and gene expression profiling reveals BCL11B as a putative oncogene in acute myeloid leukemia with 14q32 aberrations.
    Abbas S; Sanders MA; Zeilemaker A; Geertsma-Kleinekoort WM; Koenders JE; Kavelaars FG; Abbas ZG; Mahamoud S; Chu IW; Hoogenboezem R; Peeters JK; van Drunen E; van Galen J; Beverloo HB; Löwenberg B; Valk PJ
    Haematologica; 2014 May; 99(5):848-57. PubMed ID: 24441149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural variation cooperates with permissive chromatin to control enhancer hijacking-mediated oncogenic transcription.
    Botten GA; Zhang Y; Dudnyk K; Kim YJ; Liu X; Sanders JT; Imanci A; Droin N; Cao H; Kaphle P; Dickerson KE; Kumar KR; Chen M; Chen W; Solary E; Ly P; Zhou J; Xu J
    Blood; 2023 Jul; 142(4):336-351. PubMed ID: 36947815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of TLX3 and NKX2-5 in t(5;14)(q35;q32) T-cell acute lymphoblastic leukemia by remote 3'-BCL11B enhancers and coregulation by PU.1 and HMGA1.
    Nagel S; Scherr M; Kel A; Hornischer K; Crawford GE; Kaufmann M; Meyer C; Drexler HG; MacLeod RA
    Cancer Res; 2007 Feb; 67(4):1461-71. PubMed ID: 17308084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ZNF384 Fusion Oncoproteins Drive Lineage Aberrancy in Acute Leukemia.
    Dickerson KM; Qu C; Gao Q; Iacobucci I; Gu Z; Yoshihara H; Backhaus EA; Chang Y; Janke LJ; Xu B; Wu G; Papachristou EK; D'Santos CS; Roberts KG; Mullighan CG
    Blood Cancer Discov; 2022 May; 3(3):240-263. PubMed ID: 35247902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
    Punwani D; Zhang Y; Yu J; Cowan MJ; Rana S; Kwan A; Adhikari AN; Lizama CO; Mendelsohn BA; Fahl SP; Chellappan A; Srinivasan R; Brenner SE; Wiest DL; Puck JM
    N Engl J Med; 2016 Dec; 375(22):2165-2176. PubMed ID: 27959755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular dissection of prethymic progenitor entry into the T lymphocyte developmental pathway.
    Tydell CC; David-Fung ES; Moore JE; Rowen L; Taghon T; Rothenberg EV
    J Immunol; 2007 Jul; 179(1):421-38. PubMed ID: 17579063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bcl11b and combinatorial resolution of cell fate in the T-cell gene regulatory network.
    Longabaugh WJR; Zeng W; Zhang JA; Hosokawa H; Jansen CS; Li L; Romero-Wolf M; Liu P; Kueh HY; Mortazavi A; Rothenberg EV
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):5800-5807. PubMed ID: 28584128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low expression of T-cell transcription factor BCL11b predicts inferior survival in adult standard risk T-cell acute lymphoblastic leukemia patients.
    Bartram I; Gökbuget N; Schlee C; Heesch S; Fransecky L; Schwartz S; Stuhlmann R; Schäfer-Eckhart K; Starck M; Reichle A; Hoelzer D; Baldus CD; Neumann M
    J Hematol Oncol; 2014 Jul; 7():51. PubMed ID: 25023966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Dynamics in the Function of T-Lineage Regulatory Factor Bcl11b.
    Sidwell T; Rothenberg EV
    Front Immunol; 2021; 12():669498. PubMed ID: 33936112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL11B suppression does not influence CD34(+) cell differentiation and proliferation.
    Shen Q; Huang X; Chen S; Yang L; Chen S; Li B; Wu X; Grabarczyk P; Przybylski GK; Schmidt CA; Li Y
    Hematology; 2012 Nov; 17(6):329-33. PubMed ID: 23168072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the transcription factor Bcl11b in development and lymphomagenesis.
    Kominami R
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(3):72-87. PubMed ID: 22450536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The T-ALL related gene BCL11B regulates the initial stages of human T-cell differentiation.
    Ha VL; Luong A; Li F; Casero D; Malvar J; Kim YM; Bhatia R; Crooks GM; Parekh C
    Leukemia; 2017 Nov; 31(11):2503-2514. PubMed ID: 28232744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-coding Transcription Instructs Chromatin Folding and Compartmentalization to Dictate Enhancer-Promoter Communication and T Cell Fate.
    Isoda T; Moore AJ; He Z; Chandra V; Aida M; Denholtz M; Piet van Hamburg J; Fisch KM; Chang AN; Fahl SP; Wiest DL; Murre C
    Cell; 2017 Sep; 171(1):103-119.e18. PubMed ID: 28938112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b.
    Li L; Leid M; Rothenberg EV
    Science; 2010 Jul; 329(5987):89-93. PubMed ID: 20595614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl11b SWI/SNF-complex subunit modulates intestinal adenoma and regeneration after γ-irradiation through Wnt/β-catenin pathway.
    Sakamaki A; Katsuragi Y; Otsuka K; Tomita M; Obata M; Iwasaki T; Abe M; Sato T; Ochiai M; Sakuraba Y; Aoyagi Y; Gondo Y; Sakimura K; Nakagama H; Mishima Y; Kominami R
    Carcinogenesis; 2015 Jun; 36(6):622-31. PubMed ID: 25827435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes.
    Kastner P; Chan S; Vogel WK; Zhang LJ; Topark-Ngarm A; Golonzhka O; Jost B; Le Gras S; Gross MK; Leid M
    Eur J Immunol; 2010 Aug; 40(8):2143-54. PubMed ID: 20544728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.